These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

821 related articles for article (PubMed ID: 11840264)

  • 61. High treatment efficacy by dual targeting of Burkitt's lymphoma xenografted mice with a (177)Lu-based CD22-specific radioimmunoconjugate and rituximab.
    Weber T; Bötticher B; Mier W; Sauter M; Krämer S; Leotta K; Keller A; Schlegelmilch A; Grosse-Hovest L; Jäger D; Haberkorn U; Arndt MA; Krauss J
    Eur J Nucl Med Mol Imaging; 2016 Mar; 43(3):489-98. PubMed ID: 26341366
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Radioimmunotherapy of B-cell non-Hodgkin's lymphoma: from clinical trials to clinical practice.
    Juweid ME
    J Nucl Med; 2002 Nov; 43(11):1507-29. PubMed ID: 12411555
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Alpha-emitting bismuth cyclohexylbenzyl DTPA constructs of recombinant humanized anti-CD33 antibodies: pharmacokinetics, bioactivity, toxicity and chemistry.
    Nikula TK; McDevitt MR; Finn RD; Wu C; Kozak RW; Garmestani K; Brechbiel MW; Curcio MJ; Pippin CG; Tiffany-Jones L; Geerlings MW; Apostolidis C; Molinet R; Geerlings MW; Gansow OA; Scheinberg DA
    J Nucl Med; 1999 Jan; 40(1):166-76. PubMed ID: 9935073
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Radioimmunotherapy for non-Hodgkin's lymphoma.
    Emmanouilides C
    Semin Oncol; 2003 Aug; 30(4):531-44. PubMed ID: 12939722
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Apoptosis-related gene and protein expression in human lymphoma xenografts (Raji) after low dose rate radiation using 67Cu-2IT-BAT-Lym-1 radioimmunotherapy.
    Kroger LA; DeNardo GL; Gumerlock PH; Xiong CY; Winthrop MD; Shi XB; Mack PC; Leshchinsky T; DeNardo SJ
    Cancer Biother Radiopharm; 2001 Jun; 16(3):213-25. PubMed ID: 11471486
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Comparison of a tetravalent single-chain antibody-streptavidin fusion protein and an antibody-streptavidin chemical conjugate for pretargeted anti-CD20 radioimmunotherapy of B-cell lymphomas.
    Pagel JM; Lin Y; Hedin N; Pantelias A; Axworthy D; Stone D; Hamlin DK; Wilbur DS; Press OW
    Blood; 2006 Jul; 108(1):328-36. PubMed ID: 16556891
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Radioimmunotherapy for non-Hodgkin lymphoma: historical development and current status].
    Emmanouilides C
    Rev Esp Med Nucl; 2006; 25(1):42-54. PubMed ID: 16540013
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Intraperitoneal radioimmunotherapy with human monoclonal IGM in nude mice with peritoneal carcinomatosis.
    Borchardt PE; Quadri SM; Freedman RS; Vriesendorp HM
    Cancer Biother Radiopharm; 2000 Feb; 15(1):53-64. PubMed ID: 10740653
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Radioimmunotherapy with 90Y-labeled monoclonal antibodies in a nude mouse ovarian cancer model.
    Kairemo K; Ljunggren K; Strand SE; Hiltunen J; Penttilä P; Nikula T; Laine A; Wahlström T
    Acta Oncol; 1993; 32(7-8):801-5. PubMed ID: 8305229
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A comparative analysis of conventional and pretargeted radioimmunotherapy of B-cell lymphomas by targeting CD20, CD22, and HLA-DR singly and in combinations.
    Pagel JM; Orgun N; Hamlin DK; Wilbur DS; Gooley TA; Gopal AK; Park SI; Green DJ; Lin Y; Press OW
    Blood; 2009 May; 113(20):4903-13. PubMed ID: 19124831
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Rituximab blocks binding of radiolabeled anti-CD20 antibodies (Ab) but not radiolabeled anti-CD45 Ab.
    Gopal AK; Press OW; Wilbur SM; Maloney DG; Pagel JM
    Blood; 2008 Aug; 112(3):830-5. PubMed ID: 18502830
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Radioimmunotherapy of B-cell lymphoma with [131I]anti-B1 (anti-CD20) antibody.
    Kaminski MS; Zasadny KR; Francis IR; Milik AW; Ross CW; Moon SD; Crawford SM; Burgess JM; Petry NA; Butchko GM
    N Engl J Med; 1993 Aug; 329(7):459-65. PubMed ID: 7687326
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Evaluation of CD20, CD22, and HLA-DR targeting for radioimmunotherapy of B-cell lymphomas.
    Pagel JM; Pantelias A; Hedin N; Wilbur S; Saganic L; Lin Y; Axworthy D; Hamlin DK; Wilbur DS; Gopal AK; Press OW
    Cancer Res; 2007 Jun; 67(12):5921-8. PubMed ID: 17575162
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Enhanced efficacy of 90Y-radiolabeled anti-Lewis Y humanized monoclonal antibody hu3S193 and paclitaxel combined-modality radioimmunotherapy in a breast cancer model.
    Kelly MP; Lee FT; Smyth FE; Brechbiel MW; Scott AM
    J Nucl Med; 2006 Apr; 47(4):716-25. PubMed ID: 16595507
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Gamma camera scans and pretreatment tumor volumes as predictors of response and progression after Y-90 anti-CD20 radioimmunotherapy.
    Gokhale AS; Mayadev J; Pohlman B; Macklis RM
    Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):194-201. PubMed ID: 16111589
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Bespoke Pretargeted Nanoradioimmunotherapy for the Treatment of Non-Hodgkin Lymphoma.
    Au KM; Tripathy A; Lin CP; Wagner K; Hong S; Wang AZ; Park SI
    ACS Nano; 2018 Feb; 12(2):1544-1563. PubMed ID: 29361211
    [TBL] [Abstract][Full Text] [Related]  

  • 77. An alpha-particle emitting antibody ([213Bi]J591) for radioimmunotherapy of prostate cancer.
    McDevitt MR; Barendswaard E; Ma D; Lai L; Curcio MJ; Sgouros G; Ballangrud AM; Yang WH; Finn RD; Pellegrini V; Geerlings MW; Lee M; Brechbiel MW; Bander NH; Cordon-Cardo C; Scheinberg DA
    Cancer Res; 2000 Nov; 60(21):6095-100. PubMed ID: 11085533
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Astatine-211 conjugated to an anti-CD20 monoclonal antibody eradicates disseminated B-cell lymphoma in a mouse model.
    Green DJ; Shadman M; Jones JC; Frayo SL; Kenoyer AL; Hylarides MD; Hamlin DK; Wilbur DS; Balkan ER; Lin Y; Miller BW; Frost SH; Gopal AK; Orozco JJ; Gooley TA; Laird KL; Till BG; Bäck T; Sandmaier BM; Pagel JM; Press OW
    Blood; 2015 Mar; 125(13):2111-9. PubMed ID: 25628467
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Treatment of SCID/human B cell precursor ALL with anti-CD19 and anti-CD22 immunotoxins.
    Herrera L; Yarbrough S; Ghetie V; Aquino DB; Vitetta ES
    Leukemia; 2003 Feb; 17(2):334-8. PubMed ID: 12592332
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Radioimmunotherapy of human B-cell lymphoma with 90Y-conjugated antiidiotype monoclonal antibody.
    Parker BA; Vassos AB; Halpern SE; Miller RA; Hupf H; Amox DG; Simoni JL; Starr RJ; Green MR; Royston I
    Cancer Res; 1990 Feb; 50(3 Suppl):1022s-1028s. PubMed ID: 2297715
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 42.